ATLAS VENTURE ENTREPRENEURS FUND V LP's Net Worth

$617 Million

Estimate Recalculated Feb 20, 2024 04:13PM EST

Who is ATLAS VENTURE ENTREPRENEURS FUND V LP?

ATLAS VENTURE ENTREPRENEURS FUND V LP has an estimated net worth of $617 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Isilon Systems, Inc., Phase Forward Inc, ACHILLION PHARMACEUTICALS INC, NxStage Medical, Inc., MOMENTA PHARMACEUTICALS INC, and HELICOS BIOSCIENCES CORP.

SEC CIK

ATLAS VENTURE ENTREPRENEURS FUND V LP's CIK is 0001133807

Past Insider Trading and Trends

2004 was ATLAS VENTURE ENTREPRENEURS FUND V LP's most active year for acquiring shares with 45 total transactions. ATLAS VENTURE ENTREPRENEURS FUND V LP's most active month to acquire stocks was the month of May. 2005 was ATLAS VENTURE ENTREPRENEURS FUND V LP's most active year for disposing of shares, totalling 39 transactions. ATLAS VENTURE ENTREPRENEURS FUND V LP's most active month to dispose stocks was the month of May. 2007 saw ATLAS VENTURE ENTREPRENEURS FUND V LP paying a total of $2,999,997.00 for 2,987,766 shares, this is the most they've acquired in one year. In 2010 ATLAS VENTURE ENTREPRENEURS FUND V LP cashed out on 15,051,590 shares for a total of $472,764,088.82, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.84%
-183.00K
$14.97
-$2,729,560.81
2.49M
Feb 23 - Feb 24
Form 4
-33.33%
-1.34M
2.67M
Sep 29
Form 4
+801.66%
3.57M
4.01M
Jun 3
Form 4/A
445K
$6.00
$2,670,000.00
445K
May 27
Form 4
445K
$6.00
$2,670,000.00
445K
May 27 - Jun 1
Form 3
0
0
No matching records found

Isilon Systems, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.82M
$33.85
-$433,858,496.50
0
Dec 17
Form 4
-2.38%
-313.00K
$20.07
-$6,280,381.60
12.82M
Aug 23 - Aug 24
Form 4
-3.28%
-445.00K
$17.52
-$7,794,231.10
13.13M
Aug 16 - Aug 18
Form 4
-2.31%
-320.29K
$17.97
-$5,756,261.51
13.58M
Aug 4 - Aug 6
Form 4
-3.10%
-444.70K
$17.93
-$7,973,305.73
13.9M
Jul 30 - Aug 3
Form 4
-1.98%
-289.81K
$17.40
-$5,041,885.59
14.34M
Jul 26 - Jul 27
Form 4
-1.82%
-271.70K
$14.48
-$3,933,741.79
14.63M
May 11 - May 13
Form 4
-1.00%
-150.00K
$14.17
-$2,125,785.00
14.9M
May 4 - May 5
Form 4
+0.23%
69.28K
$3.40
$233,317.78
30.1M
Nov 13 - Nov 14
Form 4
+0.30%
135.9K
$3.41
$461,815.74
44.95M
Nov 10 - Nov 12
Form 4
+0.09%
25.44K
$3.45
$87,506.63
29.69M
Nov 6 - Nov 7
Form 4
+0.14%
42.81K
$3.42
$145,049.54
29.64M
Nov 4 - Nov 5
Form 4
14.78M
14.78M
Dec 20
Form 3
0
0
No matching records found

Phase Forward Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-36.45%
-1.25M
2.18M
Oct 10
Form 4
-5.25%
-190.00K
$8.97
-$1,704,300.00
3.43M
Sep 14
Form 4
-1.87%
-138.29K
$8.46
-$1,169,767.24
7.24M
Sep 9 - Sep 12
Form 4
-1.46%
-111.71K
$8.27
-$924,300.52
7.52M
Sep 7 - Sep 8
Form 4
-1.15%
-45.00K
$7.61
-$342,450.00
3.87M
Jun 14
Form 4
-1.26%
-50.00K
$6.93
-$346,500.00
3.91M
Jun 9
Form 4
-1.28%
-154.62K
$6.82
-$1,054,507.00
11.89M
Jun 6 - Jun 8
Form 4
-10.82%
-500.00K
$6.85
-$3,425,000.00
4.12M
Mar 14
Form 3
0
0
No matching records found

ACHILLION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.97M
1.97M
Oct 31
Form 3
0
0
No matching records found

NxStage Medical, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found